Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Measuring ventilation in lungs using a novel inert fluorinated (19F) gas multiple breath wash-out MRI technique to quantify treatment response in preschoolers with cystic fibrosis
FY 2020-21
Summary
Cystic fibrosis (CF) is an incurable genetic lung disease, so potential therapies must start early to slow disease progression. A treatment called CFTR modulator therapy is promising for CF and works best when started before symptoms are visible in children. Current lung function tests only identify CF in children after symptoms appear, showing a strong clinical need for new measures of lung function that are sensitive to early-stage CF. Studying the lungs by inhaling and exhaling a gas is useful because it shows interesting behaviour in the lungs. This technique, called multiple-breath washout (MBW), is a lung test used clinically to separate health from disease, but is not sensitive enough for early-stage CF. A newer, sensitive MBW technique using xenon gas MRI can also be performed, but the signal decays over time in the presence of oxygen, making it difficult to image for long times where useful clinical insight is thought to be. MBW MRI with a fluorinated gas is attractive because it can be mixed with oxygen without signal decay, letting patients breath it for a long time. This method was shown to distinguish health from disease in adults with CF but not in children or treatment response. I believe this technique is sensitive enough to detect the presence of disease before symptoms of CF are visible in children. I hope to develop it by comparing it to the existing xenon and current clinical techniques in healthy children and children with stable CF, then see if it can detect the effectiveness of CFTR modulator therapy. The ability of fluorinated gas MBW MRI to study early-stage CF is essential for the development of new treatments and the improved long-term health of children with lung disease (ex. CF, asthma) and has strong potential to be translated clinically.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
449322
Name
Alam Faiyza S
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Measuring ventilation in lungs using a novel inert fluorinated (19F) gas multiple breath wash-out MRI technique to quantify treatment response in preschoolers with cystic fibrosis
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cystic Fibrosis; Dynamic; Fluorine; Inert; Lung; Mri; Pediatric; Pfp; Treatment Response; Ventilation
Abstract
Cystic fibrosis (CF) is an incurable genetic lung disease, so potential therapies must start early to slow disease progression. A treatment called CFTR modulator therapy is promising for CF and works best when started before symptoms are visible in children. Current lung function tests only identify CF in children after symptoms appear, showing a strong clinical need for new measures of lung function that are sensitive to early-stage CF. Studying the lungs by inhaling and exhaling a gas is useful because it shows interesting behaviour in the lungs. This technique, called multiple-breath washout (MBW), is a lung test used clinically to separate health from disease, but is not sensitive enough for early-stage CF. A newer, sensitive MBW technique using xenon gas MRI can also be performed, but the signal decays over time in the presence of oxygen, making it difficult to image for long times where useful clinical insight is thought to be. MBW MRI with a fluorinated gas is attractive because it can be mixed with oxygen without signal decay, letting patients breath it for a long time. This method was shown to distinguish health from disease in adults with CF but not in children or treatment response. I believe this technique is sensitive enough to detect the presence of disease before symptoms of CF are visible in children. I hope to develop it by comparing it to the existing xenon and current clinical techniques in healthy children and children with stable CF, then see if it can detect the effectiveness of CFTR modulator therapy. The ability of fluorinated gas MBW MRI to study early-stage CF is essential for the development of new treatments and the improved long-term health of children with lung disease (ex. CF, asthma) and has strong potential to be translated clinically.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Alam, Faiyza S
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~